Curative Biosciences, Inc. (CBDX) financial statements (2020 and earlier)

Company profile

Business Address 5042 WILSHIRE BLVD.
LOS ANGELES, CA 90036
State of Incorp. NV
Fiscal Year End June 30
SIC 209 - Miscellaneous Food Preparations And Kindred (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

3/31/2018
TTM
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments   000
Cash and cash equivalents   000
Prepaid expense    0
Other undisclosed current assets     0
Total current assets:   000
Noncurrent Assets
Property, plant and equipment 0000 
Intangible assets, net (including goodwill)   (0)0
Intangible assets, net (excluding goodwill)   (0)0 
Other undisclosed noncurrent assets   0(0)0
Total noncurrent assets: 00000
Other undisclosed assets    0 
TOTAL ASSETS: 00000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 00000
Accounts payable 00000
Accrued liabilities 000  
Employee-related liabilities 0000 
Taxes payable  0000
Debt 00   
Estimated litigation liability 00   
Due to related parties   0  
Other undisclosed current liabilities 00001
Total current liabilities: 11101
Noncurrent Liabilities
Total liabilities: 11101
Stockholders' equity
Stockholders' equity attributable to parent, including: (1)(1)(1)(0)(1)
Common stock 0000 
Additional paid in capital 5352514818
Accumulated deficit (53)(53)(51)(18) 
Other undisclosed stockholders' equity attributable to parent    (30)(18)
Total stockholders' equity: (1)(1)(1)(0)(1)
TOTAL LIABILITIES AND EQUITY: 00000

Income statement (P&L) ($ in millions)

3/31/2018
TTM
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Revenues    00
Revenue, net    0 
Cost of revenue     (0)
Gross profit:    00
Operating expenses (0)(2)3(30)(1)
Other undisclosed operating loss    (0) 
Operating income (loss): (0)(2)3(30)(1)
Income (loss) before gain (loss) on sale of properties: (0)(2)3(30)(1)
Other undisclosed net loss   (7)  
Net loss: (0)(2)(3)(30)(1)
Other undisclosed net loss attributable to parent     (6)
Net loss available to common stockholders, diluted: (0)(2)(3)(30)(7)

Comprehensive Income ($ in millions)

3/31/2018
TTM
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Net loss: (0)(2)(3)(30)(1)
Comprehensive loss, net of tax, attributable to parent: (0)(2)(3)(30)(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: